{"slug":"api-magentlab-com-api-calc-4peps-afd4ee","title":"Roy 2021 4PEPS Table 3","host":"api.magentlab.com","method":"POST","resource":"https://api.magentlab.com/api/calc/4peps","category":"other","description":"Roy 2021 4PEPS Table 3: age <50 −2, 50–64 −1, ≥65 0; chronic respiratory disease −1; HR <80 −1; chest pain and acute dyspnea +1; male +2; estrogen treatment +2; prior VTE +2; syncope +2; 4-week immobility +2; SpO2 <95% +3; calf pain or unilateral edema +3; PE most likely +5. Max 22. Bands: very_low ","price_listed":0.005,"price_asked":0.007,"state":"overcharges","state_label":"Asked 1.4x its listed price for its own example","checks_7d":1,"answered_7d":1,"latency_ms_median":367,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"body":{"items":[{"age":40,"calf_pain_or_unilateral_edema":false,"chest_pain_and_acute_dyspnea":false,"chronic_respiratory_disease":false,"heart_rate_bpm":90,"hormonal_estrogenic_treatment":false,"immobility_4w":false,"pe_most_likely":false,"personal_history_vte":false,"sex":"female","spo2_percent":98,"syncope":false},{"age":40,"calf_pain_or_unilateral_edema":false,"chest_pain_and_acute_dyspnea":false,"chronic_respiratory_disease":false,"heart_rate_bpm":90,"hormonal_estrogenic_treatment":false,"immobility_4w":false,"pe_most_likely":false,"personal_history_vte":false,"sex":"female","spo2_percent":98,"syncope":false}]},"method":"POST","type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (integer 18-120). Roy 2021 Table 3: <50 scores −2; 50-64 scores −1; ≥65 scores 0 (65-80 and >80 were not independently associated).","type":"integer"},"calf_pain_or_unilateral_edema":{"description":"Calf pain and/or unilateral lower-limb edema as assigned by the caller (Roy 2021 Table 3). true scores +3. magent does not examine the patient.","type":"boolean"},"chest_pain_and_acute_dyspnea":{"description":"Both chest pain and acute dyspnea present as assigned by the caller (Roy 2021 Table 3). true scores +1. magent does not examine the patient.","type":"boolean"},"chronic_respiratory_disease":{"description":"Chronic respiratory disease (Roy 2021 Table 3). true scores −1. Assigned by the caller. magent does not examine the patient.","type":"boolean"},"heart_rate_bpm":{"description":"Heart rate in beats per minute (integer 30-220). Table 3: <80 scores −1. 80-100 was not independently associated; this tool does not add tachycardia points.","type":"integer"},"hormonal_estrogenic_treatment":{"description":"Hormonal estrogenic treatment as assigned by the caller (Roy 2021 Table 3). true scores +2.","type":"boolean"},"immobility_4w":{"description":"Immobility within 4 weeks (Roy 2021 Table 3 footnote a): surgery, lower limb plaster cast, or bedridden more than 3 days for an acute medical condition. true scores +2. Assigned by the caller. magent does not examine the patient.","type":"boolean"},"pe_most_likely":{"description":"PE is the most likely diagnosis as assigned by the caller (Roy 2021 Table 3). true scores +5. magent does not examine the patient or decide PE most likely.","type":"boolean"},"personal_history_vte":{"description":"Personal history of VTE as assigned by the caller (Roy 2021 Table 3). true scores +2.","type":"boolean"},"sex":{"description":"female or male (Roy 2021 Table 3). Male scores +2. Female scores 0. Assigned by the caller.","enum":["female","male"],"type":"string"},"spo2_percent":{"description":"Oxygen saturation percent (50-100). Roy 2021 Table 3: <95 scores +3; 95 and above score 0.","type":"number"},"syncope":{"description":"Syncope as assigned by the caller (Roy 2021 Table 3). true scores +2. magent does not examine the patient.","type":"boolean"}},"required":["age","chronic_respiratory_disease","heart_rate_bpm","chest_pain_and_acute_dyspnea","sex","hormonal_estrogenic_treatment","personal_history_vte","syncope","immobility_4w","spo2_percent","calf_pain_or_unilateral_edema","pe_most_likely"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.007,"price_match":false,"latency_ms":367,"error":null}],"description_full":"Roy 2021 4PEPS Table 3: age <50 −2, 50–64 −1, ≥65 0; chronic respiratory disease −1; HR <80 −1; chest pain and acute dyspnea +1; male +2; estrogen treatment +2; prior VTE +2; syncope +2; 4-week immobility +2; SpO2 <95% +3; calf pain or unilateral edema +3; PE most likely +5. Max 22. Bands: very_low <0, low 0–5, moderate 6–12, high ≥13. Not imaging or D-dimer. magent does not examine the patient or decide PE most likely.","last_updated":"2026-09-28T14:23:16.664Z","schemes":["exact"]}